The polymorphism of the locus control region lying downstream the human IgH locus is restricted to hs1,2 but not to hs3 and hs4 enhancers

Immunology Letters

Volumn 94, Issue 1-2, 2004, Pages 77-81

  Guglielmi, Laurence ^a   Truffinet, Véronique ^a   Magnoux, Emmanuelle ^a   Cogné, Michel ^a   Denizot, Yves ^a  

^a CNRS   (France)

Author keywords

3 IgH enhancers; hs1,2; hs3; hs4; Nuclear factor binding sites; Polymorphism

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; NUCLEAR FACTOR;

ARTICLE; BINDING SITE; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ENHANCER REGION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; PRIORITY JOURNAL; REGULATOR GENE; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

BASE SEQUENCE; BINDING SITES; ENHANCER ELEMENTS (GENETICS); HUMANS; IMMUNOGLOBULIN ALPHA-CHAINS; IMMUNOGLOBULIN HEAVY CHAINS; LOCUS CONTROL REGION; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRANSCRIPTION FACTORS;

EID: 3242675901     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.04.003     Document Type: Article

References (29)

1. Guglielmi L., Truffinet L., Cogné M., Denizot Y. The β-globin HS4 insulator confers copy-dependent expression of IgH regulatory elements in stable B cell transfectants. Immunol. Lett. 89:2003;119-123
2. Khamlichi A.A., Pinaud E., Decourt C., Chauveau C., Cogné M. The 3′ IgH regulatory region: a complex structure in a search for a function. Adv. Immunol. 75:2000;317-345
3. Mills F.C., Harindranath N., Mitchell M., Max E.E. Enhancer complexes located downstream of both human immunoglobulin alpha genes. J. Exp. Med. 186:1997;845-858
4. Pinaud E., Aupetit C., Chauveau C., Cogné M. Identification of a homologue of the Cα3′/hs3 enhancer and of an allelic variant of the 3′IgH/hs1,2 enhancer downstream the human immunoglobulin α1 gene. Eur. J. Immunol. 27:1997;2981-2985
5. Pinaud E., Khamlichi A.A., Le Morvan C., Drouet M., Nalesso V., Le Bert M., Cogné M. Localization of the 3′IgH locus elements that effect long-distance regulation of class switch recombination. Immunity. 15:2001;187-199
6. Guglielmi L., Le Bert M., Truffinet V., Cogné M., Denizot Y. Insulators to improve expression of a 3′IgH LCR-driven reporter gene in transgenic mouse model. Biochem. Biophys. Res. Commun. 307:2003;466-471
7. Guglielmi L., Le Bert M., Comte I., Dessain M.L., Drouet M., Ayer-Le Lievre C., Cogné M., Denizot Y. Combination of 3′ and 5′ IgH regulatory elements mimics the B-specific endogenous expression pattern of IgH genes from pro-B cells to mature B cells in a transgenic mouse model. Biochim. Biophys. Acta. 1642:2003;181-190
8. Denizot Y., Pinaud E., Aupetit C., Le Morvan C., Magnoux E., Aldigier J.C., Cogné M. Polymorphism of the human α1 immunoglobulin gene 3′ enhancer hs1,2 and its relation to gene expression. Immunology. 103:2001;35-40
9. Aupetit C., Drouet M., Pinaud E., Denizot Y., Aldigier J.C., Bridoux F., Cogne M. Alleles of the α1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy towards renal failure. Kidney Int. 58:2000;966-971
10. Drouet M., Aupetit C., Denizot Y., Bois M., Bridoux F., Aldigier J.C., Cogne M. Analysis of three genetic markers in IgA nephropathy patients from single region. Clin. Nephrol. 57:2002;253-260
11. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74:1977;5463-5467
12. Heckman C.A., Cao T., Somsouk L., Duan H., Mehew J.W., Zhang C.Y., Boxer L.M. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of Bcl2. Cancer Res. 63:2003;6666-6673
13. Michaelson J.S., Singh M., Snapper C.M., Sha W.C., Baltimore D., Birshtein B.K. Regulation of 3′IgH enhancers by a common set of factors, including κB-binding proteins. J. Immunol. 156:1996;2828-2839
14. Gordon S.J., Saleque S., Birshtein B.K. Yin Yang 1 is a lipopolysaccharide-inducible activator of the murin IgH enhancer, hs3. J. Immunol. 170:2003;5549-5557
15. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:1998;362-367
16. Bradney C., Hjelmeland M., Komatsu Y., Yoshida M., Yao T.P., Zhuang Y. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278:2003;2370-2376
17. Gugasyan R., Grumont R., Grossmann M., Nakamura Y., Pohl T., Nesic D. Gerond S, Rel/KF-kappaB transcription factors: key mediators of B-cell activation. Immunol. Rev. 176:2000;134-140
18. Pankratova E.V., Deyev I.E., Zhenilo S.V., Polanovsky O.L. Tissue-specific isoforms of the ubiquitous transcription factor Oct-1. Mol. Genet. Genomics. 266:2001;239-245
19. Heavey B., Charalambous C., Cobaleda C., Busslinger M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J. 22:2003;3887-3897
20. Lecuyer E., Herblot S., Saint-Denis M., Martin R., Begley C.G., Porcher C., Orkin S., Hoang T. The SCL complex regulates c-kit expression in hematopoietic cells through functional interactions with SP1. Blood. 100:2002;2430-2440
21. Perrotti D., Melotti P., Skorski T., Casella I., Peschle C., Calabretta B. Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic cells: correlation with negative regulation of CD34 and c-myb promoter activity. Mol. Cell Biol. 15:1995;6075-6087
22. Thiagalingam A., De Bustros A., Borges M., Jasti R., Compton D., Diamond L., Mabry M., Ball D.W., Baylin S.B., Nelkin B.D. RREB-1, a novel zing finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol. Cell Biol. 16:1996;5335-5345
23. 2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:1994;2801-2810
24. Choi J.K., Shen C.P., Radomska H.S., Eckhardt L.A., Kadesch T. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 15:1996;5014-5021
25. Sekido R., Murai K., Funahashi J., Kamachi Y., Fujisawa-Sehara A., Nabeshima Y., Kondoh H. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol. Cell Biol. 14:1994;5692-5700
26. Fujita K., Miki N., Mojica M.P., Takao S., Phuchareon J., Nishikawa S., Sudo T., Tokuhisa T. B cell development is perturbed in bone marrow from c-fos/v-jun doubly transgenic mice. Int. Immunol. 5:1993;227-230
27. Müschen M., Lee S., Zhou G., Feldhahn N., Barath V.S., Chen J., Moers C., Krönke M., Rowley J.D., Wang S.M. Molecular portraits of B cell lineage commitment. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10014-10019
28. Linderson Y., Cross D., Neurath M.F., Pettersson S. NFE, a new transcriptional activator that facilitates p50 and c-rel-dependent IgH 3′ enhancer activity. Eur. J. Immunol. 27:1997;468-475
29. Ishihara K., Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim. Biophys. Acta. 1592:2002;281-296